AU2002331530A1 - Thyroid therapeutic agents containing partial glycerides and dextrin - Google Patents

Thyroid therapeutic agents containing partial glycerides and dextrin

Info

Publication number
AU2002331530A1
AU2002331530A1 AU2002331530A AU2002331530A AU2002331530A1 AU 2002331530 A1 AU2002331530 A1 AU 2002331530A1 AU 2002331530 A AU2002331530 A AU 2002331530A AU 2002331530 A AU2002331530 A AU 2002331530A AU 2002331530 A1 AU2002331530 A1 AU 2002331530A1
Authority
AU
Australia
Prior art keywords
therapeutic agents
agents containing
partial glycerides
dextrin
containing partial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002331530A
Inventor
Jens Flemming
Karsten Groger
Reinhard Schmitz
Karl-Albrecht Stauske
Jens Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlin Chemie AG
Original Assignee
Berlin Chemie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie AG filed Critical Berlin Chemie AG
Publication of AU2002331530A1 publication Critical patent/AU2002331530A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to oral therapeutic agents containing at least one active ingredient and, as adjuvants, dextrins and higher-chain partial glycerides as well as additional pharmaceutically acceptable adjuvants and excipients. The invention makes it possible to forgo cost-intensive bioavailability and bioequivalence tests for all (conceivable) dosage strengths located within the established linearity range, in particular, to realize a dosage scheme individually adapted to the patient, and to reduce the, until now, customary regular medical check-ups of patients with an L-thyroxine medication.
AU2002331530A 2001-07-17 2002-07-17 Thyroid therapeutic agents containing partial glycerides and dextrin Abandoned AU2002331530A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10136615.9 2001-07-17
DE10136615A DE10136615A1 (en) 2001-07-17 2001-07-17 thyroid therapeutics
PCT/DE2002/002673 WO2003007994A2 (en) 2001-07-17 2002-07-17 Thyroid therapeutic agents containing partial glycerides and dextrin

Publications (1)

Publication Number Publication Date
AU2002331530A1 true AU2002331530A1 (en) 2003-03-03

Family

ID=7693293

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002331530A Abandoned AU2002331530A1 (en) 2001-07-17 2002-07-17 Thyroid therapeutic agents containing partial glycerides and dextrin

Country Status (5)

Country Link
EP (1) EP1408948B1 (en)
AT (1) ATE374020T1 (en)
AU (1) AU2002331530A1 (en)
DE (3) DE10136615A1 (en)
WO (1) WO2003007994A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20022394A1 (en) 2002-11-13 2004-05-14 Bracco Spa USE OF 3-SULPHATE TRIODOTHYRONIN AS A THYROIMIMETIC ACTIVITY AND RELATED PHARMACEUTICAL FORMULATIONS.
ITMI20110713A1 (en) 2011-04-29 2012-10-30 Bracco Imaging Spa PROCESS FOR THE PREPARATION OF A SULFATE DERIVATIVE DI3,5-DIIODO-O- [3-IODOFENIL] -L-TIROSINA
IT1395454B1 (en) * 2009-03-24 2012-09-21 Altergon Sa PHARMACEUTICAL COMPOSITIONS AND FORMS FOR ORAL ADMINISTRATION OF THYROID ORMONS ABLE TO COUNTER THE ACTION OF SEQUESTRANT AGENTS IN THE GASTROINTESTINAL TRACT

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02264721A (en) * 1989-04-05 1990-10-29 Tama Seikagaku Kk Production of powdery vitamin e
US5562921A (en) * 1994-07-15 1996-10-08 Sherman; Bernard C. Stable solid pharmaceutical compositions containing enalapril maleate
US6190591B1 (en) * 1996-10-28 2001-02-20 General Mills, Inc. Embedding and encapsulation of controlled release particles

Also Published As

Publication number Publication date
DE10136615A1 (en) 2003-02-06
DE50210985D1 (en) 2007-11-08
EP1408948A2 (en) 2004-04-21
WO2003007994A3 (en) 2003-05-30
DE10293092D2 (en) 2004-05-27
EP1408948B1 (en) 2007-09-26
ATE374020T1 (en) 2007-10-15
WO2003007994A2 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
NZ513304A (en) Combinations of formoterol and a tiotropium salt
ECSP083351A (en) PHARMACEUTICAL COMPOSITIONS
NZ514574A (en) Novel method of treatment
AR023972A1 (en) COMPOSITIONS OF MEDICINES BASED ON ANTI-POLINERGICALLY ACTIVE AND BETA-MIMETIC COMPOUNDS
HK1043048A1 (en) Combinations of formoterol and mometasone furoate
IL149147A0 (en) Use of oxcarbazepine for the manufacture of oral dosage form medicament
UA88270C2 (en) Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes
AU5562101A (en) Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
DE1001772T1 (en) IMPROVED ADMINISTRATION TECHNOLOGY FOR MULTIPLE ADMINISTRATION
BRPI0311701B8 (en) multiparticulate dosage pharmaceutical formulation coated with controlled release of lamotrigine
DE60233898D1 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON DISEASE WITH HIGH ROTIGOTINE PLASMAS MIRRORS
IL165786A0 (en) Ibuprofen suspension
PT1383752E (en) 3-PIPERIDINOPROPYOPHENONES DETERMINED AS WELL AS PHARMACONS CONTAINING THESE COMPOUNDS
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
WO2002011694A3 (en) Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
WO2005044187A3 (en) Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
HUP0400115A2 (en) Pharmaceutical composition for the intramuscular administration of fulvestrant
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
AU2002331530A1 (en) Thyroid therapeutic agents containing partial glycerides and dextrin
MD2549F1 (en) Method of treatment of the chronic viral hepatitis C
CA2450915A1 (en) Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure
GB9930077D0 (en) Medicaments
GB9930075D0 (en) Medicaments
WO2004071398A3 (en) Pharmaceutical patch
AR109456A2 (en) USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase